SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-011133
Filing Date
2023-03-31
Accepted
2023-03-31 07:10:42
Documents
86
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ikt-20221231.htm   iXBRL 10-K 3729315
2 EX-21.1 ikt-ex21_1.htm EX-21 9293
3 EX-31.1 ikt-ex31_1.htm EX-31 19593
4 EX-31.2 ikt-ex31_2.htm EX-31 19497
5 EX-32.1 ikt-ex32_1.htm EX-32 12422
6 EX-32.2 ikt-ex32_2.htm EX-32 12422
7 GRAPHIC img34741784_0.jpg GRAPHIC 29111
8 GRAPHIC img34741784_1.jpg GRAPHIC 59662
9 GRAPHIC img34741784_2.jpg GRAPHIC 23080
10 GRAPHIC img34741784_3.jpg GRAPHIC 34197
11 GRAPHIC img34741784_4.jpg GRAPHIC 26236
12 GRAPHIC img34741784_5.jpg GRAPHIC 53200
13 GRAPHIC img34741784_6.jpg GRAPHIC 15849
14 GRAPHIC img34741784_7.jpg GRAPHIC 13152
  Complete submission text file 0000950170-23-011133.txt   10904699

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ikt-20221231_pre.xml EX-101.PRE 389835
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ikt-20221231_cal.xml EX-101.CAL 42077
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ikt-20221231_def.xml EX-101.DEF 224306
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ikt-20221231_lab.xml EX-101.LAB 514182
19 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ikt-20221231.xsd EX-101.SCH 62964
80 EXTRACTED XBRL INSTANCE DOCUMENT ikt-20221231_htm.xml XML 1410887
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39676 | Film No.: 23783178
SIC: 2836 Biological Products, (No Diagnostic Substances)